课题基金 / 基金详情

Cancer therapy using labeled antibodies

Cancer therapy using labeled antibodies
使用标记抗体进行癌症治疗
批准号:
17016008
负责人:
ENDO Keigo
金额:
$81.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2009

项目摘要

项目成果

ENDO Keigo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Antibodies cancer-associated antigens were selected and labeled with various radionuclides. In tumor-bearing mice, radiolabeled antibody showed a high accumulation in the tumor and clear PET images of the tumor. In therapeutic study using 90Y-labeled antibody, slow progression of tumor was observed and substantial tumor size reduction was also observed in some cases. These results indicated usefulness of the cancer therapy using radiolabed antibodies, and new labeled antibodies were developed useful for the therapy of cancer.
期刊论文(137)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1349-7006.2010.01480.x
发表时间: 2010-04-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Paudyal, Pramila, Paudyal, Bishnuhari, Endo, Keigo]
通讯作者: Endo, Keigo
DOI: --
发表时间: 2010
期刊: British Journal of Radiology 83
影响因子: --
作者: [小島道一, 鄭城尤, Paudyal P, Paudyal B]
通讯作者: Paudyal B
DOI: 10.1007/s12149-009-0265-1
发表时间: 2009-07-01
期刊: ANNALS OF NUCLEAR MEDICINE
影响因子: 2.6
作者: [Hanaoka, Hirofumi, Katagiri, Toyomasa, Endo, Keigo]
通讯作者: Endo, Keigo
Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (90Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma.
使用抗 CD20 鼠放射免疫结合物 (90Y-ibritumomab tiuxetan) 治疗复发性或难治性惰性 B 细胞淋巴瘤的放射免疫治疗的 I 期研究。
DOI: --
发表时间: 2005
期刊: Cancer Sci 96
影响因子: --
作者: [Watanabe Watanabe T, Terui S, Itoh K, Terauchi T, Igarashi T, Usubuchi N, Nakata M, Nawano S, Sekiguchi N, Kusumoto S, Tanimoto K, Kobayashi Y, Endo K, Seriu T, Hayashi., Tobinai K]
通讯作者: Tobinai K
46
    Cell tracking technique of iPS cells and clinical application using PET and MRI
    Development of F-18 (positron emitter) labeled serotonin derivatives useful for the pathophysiology of depression.
    • 批准号:
      13470179
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.34万
    • 财政年份:
      2001
    • 负责人:
      ENDO Keigo
    • 依托单位:
    セロトニンアナログ^<18>F-メチルトリプトファンを用いたうつ病発症機序の基礎的研究
    • 批准号:
      11670868
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      1999
    • 负责人:
      ENDO Keigo
    • 依托单位:
    New diagnostic and therapeutic radiopharmaceuticals using radiolabeled peptides develoopted by the genetic engineering.
    • 批准号:
      09470197
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.1万
    • 财政年份:
      1997
    • 负责人:
      ENDO Keigo
    • 依托单位:
    海外基金